openPR Logo
Press release

Bispecific Antibodies Market Opportunity Analysis, 2018-2026

08-17-2018 03:56 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Bispecific Antibodies Market Opportunity Analysis, 2018-2026

Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a technologically advanced solution for dual targeting strategies within same molecule.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/19

Due to its dual specificity, bispecific antibody can aid in redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. Catumaxomab and blinatumomab are the two U.S. FDA approved bispecific antibody products, which would fuel growth of the bispecific antibodies market. Bispecific antibodies can be divided into three main classes namely, fragment, symmetric, and asymmetric antibodies. Fragment bispecific antibodies such as a nanobody DART and BiTE are currently undergoing clinical trials. Likewise, tetravalent BsAb - DVD and DAF symmetric antibodies are under research. Companies such as Sanofi S.A., Merck & Co., Inc. and Genentech, Inc. are conducting research on symmetric bispecific antibodies. BEAT, duobody, and crossmab are examples of asymmetric bispecific antibodies, which are currently being researched by Glenmark Pharmaceuticals, Eli Lilly and Company, and Genmab A/S.

Catumaxomab – the first Bispecific antibody boost growth of the bispecific antibodies market

As of 2015, over 60 different BsAb formats have been developed, with some making their way into the clinical trials. Bispecific antibodies market growth is increasing due to the limitation of monoclonal antibodies in drug resistance and failure to respond in treatment. Hence, the bispecific antibodies market is projected to gain significant growth traction in the near future.

Catumaxomab is a rat – mouse hybrid monoclonal bispecific trifunctional antibody used to treat malignant ascites. It was developed by Fresenius Biotech and Trion Pharma. Catumaxomab was approved in Europe in 2009 and is undergoing clinical trials in the U.S. Sold under the brand name Removab, Catumaxomab is administered to patients with EpCAM-poisitve carcinoma.

North America and Europe are major regions for Bispecific antibodies market

In Europe and North America, incidence of diseases such as lung cancer, cervical cancer, breast cancer, and prostate cancer is increasing, with the regions accounting for the highest incidence rate for these diseases worldwide. Moreover, with these regions being home to major players, these are the largest bispecific antibodies market. Supportive government initiatives are further fueling growth of bispecific antibody treatment markets in North America and Europe. Increasing healthcare access and awareness in developing regions such as Asia Pacific, Latin America, and Middle East are projected to propel demand for BsAb owing to fuel growth of the bispecific antibodies market in the near future.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/19

Increasing investments to harness the potential of highly effective BsAb Drug Therapy

Various pharmaceutical companies are actively involved in development and manufacture of bispecific antibodies. MedImmune, LLC and Abpro, collaborated in December 2016 to develop novel bispecific antibody, Ang2-VEGF, which targets angiopoietin-2 and vascular endothelial growth factor. Government funding is projected to further encourage research and development in this field.

Key players involved in the Bispecific antibodies market include

Some of the key players in Bispecific antibodies market are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and F. Hoffmann-La Roche AG.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bispecific Antibodies Market Opportunity Analysis, 2018-2026 here

News-ID: 1186157 • Views: 487

More Releases from Coherent Market Insights

Cryptocurrency Mining Equipment Market is Expected to Witness Stunning Growth Ti …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗰𝗿𝘆𝗽𝘁𝗼𝗰𝘂𝗿𝗿𝗲𝗻𝗰𝘆 𝗺𝗶𝗻𝗶𝗻𝗴 𝗲𝗾𝘂𝗶𝗽𝗺𝗲𝗻𝘁 𝗺𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝗱 𝘁𝗼 𝗲𝘅𝗵𝗶𝗯𝗶𝘁 𝗮 𝗖𝗔𝗚𝗥 𝗼𝗳 𝟭𝟴.𝟲𝟴% 𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗽𝗲𝗿𝗶𝗼𝗱. Summary of the Report - CMI's latest report, global "Cryptocurrency Mining Equipment Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Advanced Micro Devices, Inc., Russian Miner Coin, Halong Mining, Zhejiang Ebang Communication Co.,
Traffic Management System Market is projected to show significant growth by 2027 …
𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝘂𝗿𝗯𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗴𝗿𝗼𝘄𝗶𝗻𝗴 𝗽𝘂𝗯𝗹𝗶𝗰 𝗰𝗼𝗻𝗰𝗲𝗿𝗻𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘀𝗮𝗳𝗲𝘁𝘆 𝗮𝗿𝗲 𝗺𝗮𝗷𝗼𝗿 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗴𝗿𝗼𝘄𝘁𝗵 𝗼𝗳 𝘁𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝘁𝗿𝗮𝗳𝗳𝗶𝗰 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝘀𝘆𝘀𝘁𝗲𝗺 𝗺𝗮𝗿𝗸𝗲𝘁 Summary of the Report - CMI's latest report, global "Traffic Management System Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Atkins Group, Affiliated Computer Services, Inc., Alstom SA,
Workplace Transformation Market Growth Opportunities, SWOT Analysis, Know the Co …
𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗮𝗱𝗼𝗽𝘁𝗶𝗼𝗻 𝗼𝗳 𝗻𝗲𝘄 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝗱 𝗰𝗵𝗮𝗻𝗴𝗲 𝗶𝗻 𝘄𝗼𝗿𝗸 𝗰𝘂𝗹𝘁𝘂𝗿𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗲𝗻𝘁𝗲𝗿𝗽𝗿𝗶𝘀𝗲𝘀 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗸𝗲𝘆 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝗴𝗿𝗼𝘄𝘁𝗵 𝗼𝗳 𝘁𝗵𝗲 𝘄𝗼𝗿𝗸𝗽𝗹𝗮𝗰𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝗿𝗸𝗲𝘁 Summary of the Report - CMI's latest report, global "Workplace Transformation Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - NTT Data Corporation , Cisco Systems, Inc.
Automotive Lighting Market Demand, Overview, Size, Trend, and Key Players Names: …
𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗻𝗲𝘄 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗶𝗻 𝗹𝗶𝗴𝗵𝘁𝗶𝗻𝗴 𝗶𝘀 𝘁𝗵𝗲 𝗼𝗻𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗸𝗲𝘆 𝗳𝗮𝗰𝘁𝗼𝗿 𝗽𝗿𝗼𝗽𝗲𝗹𝗹𝗶𝗻𝗴 𝗴𝗿𝗼𝘄𝘁𝗵 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗮𝗿𝗸𝗲𝘁. Summary of the Report - CMI's latest report, global "Automotive Lighting Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - General Electric, Magneti Marelli S.P.A, Koito Manufacturing Co. Ltd, Valeo, Hella KGaA Hueck

All 5 Releases


More Releases for Bispecific

Bispecific Antibodies Market Plying for Significant Growth During 2023
Bispecific antibodies are recognized as artificial protein where two or more antigen recognizing elements are combining together to form a single construct. Bispecific antibodies are able to bind into two or more targets at a time. Moreover, these antibodies might bridge two targets together and are able to present high chances of gaining therapeutic effects (bring cancer cell within striking distance). The various formats of bispecific antibodies include quadromas, chemical
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market to Grow Globally
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies
Bispecific Antibodies Market - Trends, Outlook, and Opportunity Analysis, 2016-2 …
Key players involved in the Bispecific antibodies market include Some of the key players in Bispecific antibodies market are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and F. Hoffmann-La Roche AG. Get Free PDF Research Brochure for more Professional and Technical Insights : https://www.coherentmarketinsights.com/insight/request-sample/19 Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two
Bispecific Antibodies Market Research Report Forecast to 2015- 2023
Bispecific antibodies are recognized as artificial protein where two or more antigen recognizing elements are combining together to form a single construct. Bispecific antibodies are able to bind into two or more targets at a time. Moreover, these antibodies might bridge two targets together and are able to present high chances of gaining therapeutic effects (bring cancer cell within striking distance). The various formats of bispecific antibodies include quadromas, chemical
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies